Back to results
US 2009/0022802 A1Published application
Cardiomyopathy therapeutic agent
OwnerYasuhiko Tabata, Masashi Komedainventors
Life of this patent
Estimating the term…
Abstract
The present invention provides a cardiomyopathy therapeutic agent that contains hepatocyte growth factor (HGF) and gelatin hydrogel, and gradually releases HGF, which is useful in treating cardiomyopathy.
Claims9
-5. (canceled)
A method of treating cardiomyopathy comprising:
- administering to a subject an effective amount of a cardiomyopathy therapeutic agent that contains hepatocyte growth factor (HGF) and gelatin hydrogel, wherein the gelatin hydrogel is selected such that it gradually releases HGF for about 4 weeks when used.
Dependencies are inferred from the claim text.